Fat cells can grow in two different ways — and the difference shapes your health
Not all fat storage is the same. New research shows that fat tissue can expand in two fundamentally different ways, and that which path it takes — cells getting bigger, or new…
Fat tissue has long been seen as a passive energy depot, but that picture is outdated. It is an active organ that produces hormones, communicates with the immune system, and continuously remodels itself. How it adapts to an energy surplus or deficit turns out to be a central question for metabolic health. Researchers developed a new CRISPR imaging platform in zebrafish larvae — transparent animals whose fat stores can be tracked in real time — to investigate this question at scale.
The key distinction: hypertrophic growth, where existing fat cells (adipocytes) swell in size, versus hyperplastic growth, where new fat cells are generated. The first pattern is associated with insulin resistance and elevated risk of type 2 diabetes and heart disease. The second — more, but smaller, cells — appears to be metabolically protective. In other words: it’s not how much fat a person has, but how that fat grows, that determines a significant part of their health risk.
CRISPR as a lens on fat biology
The power of the approach lies in its scale and precision. Using their CRISPR screening platform, researchers could test more than a thousand genes simultaneously for their effect on fat cell behaviour, while real-time microscopy revealed what was changing in the tissue. This allowed them to identify a set of genes that regulate the balance between hypertrophic and hyperplastic growth — candidates that in humans may hold the key to metabolic vulnerability or protection.
For the longevity field, this matters because metabolic health in middle age is one of the strongest predictors of health in later life. Insulin resistance — a consequence of hypertrophic fat growth — is not only a risk factor for diabetes but also for neurodegeneration and accelerated biological aging. If the molecular switches between the two growth modes can be better understood, potential intervention targets emerge — not to remove fat, but to make it grow in healthier ways.
From zebrafish to humans: how much translates?
Zebrafish larvae are a convenient model — transparent, genetically tractable, fast — but they are not humans. The genes that regulate fat cell balance in zebrafish will need to be validated in mammalian models and ultimately in human adipose tissue. That is standard science, but it also means clinical translation is still years away. What the study does deliver is a sharper new view of a fundamental biological process that has until now been difficult to study at the required scale.